HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Henz Selected Research

5- (3- methyl- 1- triazeno)imidazole- 4- carboxamide (MTIC)

1/2000Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Henz Research Topics

Disease

1Melanoma (Melanoma, Malignant)
01/2000

Drug/Important Bio-Agent (IBA)

15- (3- methyl- 1- triazeno)imidazole- 4- carboxamide (MTIC)IBA
01/2000
1Temozolomide (Temodar)FDA LinkGeneric
01/2000
1Dacarbazine (DIC)FDA LinkGeneric
01/2000